Clinical Research

Hall of Fame Health partnership set to advance study of neurodegeneration via new PET imaging agent

The organization is teaming up with CereMark Pharma to conduct research on improving outcomes in soldiers and athletes with neurodegenerative conditions.

AI tool detects PE missed by rads

Commercially available AI tool detects 76% of PE that rads initially missed on CT

Improving the detection of pulmonary embolism has been a popular target among multiple AI vendors.

Thumbnail

Spatial patterns on imaging could predict Alzheimer's years before cognitive symptoms emerge

These subtle changes precede greater tissue loss related to cognitive impairment.

Anne Kroman, DO, PhD, director of lead management and the device clinic, and assistant professor at Medical University of South Carolina (MUSC), explains more women need to be included in clinical trials to help better understand sex differences in electrophysiology presentations.

Why electrophysiology trials need to include more women

Most EP clinical study data are from men, Anne Kroman, DO, explained in an interview. This is a significant problem, she said, because heart rhythm issues look quite different in women. 

auditorium conference

The rise of bogus healthcare conferences

A conference on neurology is described by reporters as "shambolic," offering only bare bones presentations and accommodations. And the number of these events may be on the rise.

Thumbnail

New PET method spots early signs of inflammatory bowel disease

The novel method could potentially guide decisions on when patients should start treatment. 

Researchers have developed artificial blood vessels that could be as strong and durable as the real things, publishing their work in Advanced Materials Technologies.[1] The group hopes its work could go on to make a significant impact in care for heart bypass patients.

Artificial blood vessels could limit risks during heart bypass procedures

Even grafts that represent the current gold standard for bypass surgeries are associated with high failure rates, researchers noted. They think these 3D-printed blood vessels could provide considerable value. 

Edwards Lifesciences Sapien 3 transcatheter heart valve used for Mitral Valve-in-Valve

Transcatheter mitral valve-in-valve replacement benefits intermediate-risk patients

New one-year data suggests transseptal MViV with a Sapien 3 heart valve is a "favorable and safe procedure." Researchers plan to follow patients for a total of 10 years.